The A2B trial, antibiotic prophylaxis for excision-graft surgery in burn patients: a multicenter randomized double-blind study
Authors:
- François DépretFDFrançois Dépret
- Mathieu JeanneMJMathieu Jeanne
- Kada KloucheKada Klouche
- Thomas LeclercTLThomas Leclerc
- Karine Nouette-GaulainKarine Nouette-Gaulain
- Olivier PantetOPOlivier Pantet
- Francis RémerandFRFrancis Rémerand
- Antoine RoquillyARAntoine Roquilly
- Anne-Françoise RousseauARAnne-Françoise Rousseau
Open Access
- 25 November 2020
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 21 (1) , 1-10
Abstract
Background: The indication for antibiotic prophylaxis in burn patients remains highly controversial, with no consensus having been reached. The objective of antibiotic prophylaxis is to reduce the risk of postoperative local and systemic infections. Burn surgery is associated with a high incidence of bacteremia, postoperative infections, and sepsis. However, antibiotic prophylaxis exposes patients to the risk of selecting drug-resistant pathogens as well as to the adverse effects of antibiotics (i.e., Clostridium difficile colitis). The lack of data precludes any strong international recommendations regarding perioperative prophylaxis using systemic antibiotics in this setting. The goal of this project is therefore to determine whether perioperative systemic antibiotic prophylaxis can reduce the incidence of postoperative infections in burn patients. Methods: The A2B trial is a multicenter (10 centers), prospective, randomized, double-blinded, placebo-controlled study. The trial will involve the recruitment of 506 adult burn patients with a total body surface area (TBSA) burn of between 5 and 40% and requiring at least one excision-graft surgery for deep burn injury. Participants will be randomized to receive antibiotic prophylaxis (antibiotic prophylaxis group) or a placebo (control group) 30 min before the incision of the first two surgeries. The primary outcome will be the occurrence of postoperative infections defined as postoperative sepsis and/or surgical site infection and/or graft lysis requiring a new graft within 7 days after surgery. Secondary outcomes will include mortality at day 90 postrandomization, skin graft lysis requiring a new graft procedure, postoperative bacteremia (within 48 h of surgery), postoperative sepsis, postoperative surgical site infection, number of hospitalizations until complete healing (> 95% TBSA), number of hospitalization days living without antibiotic therapy at day 28 and day 90, and multiresistant bacterial colonization or infection at day 28 and day 90. Discussion: The trial aims to provide evidence on the efficacy and safety of antibiotic prophylaxis for excision-graft surgery in burn patients. Trial registration: ClinicalTrials.gov NCT04292054. Registered on 2 March 2020Keywords
Funding Information
- PHRC-N 2018 (PHRCN-18-0529)
This publication has 16 references indexed in Scilit:
- Impact of an Acinetobacter baumannii outbreak on kidney events in a burn unit: A targeted machine learning analysisAmerican Journal of Infection Control, 2019
- Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort studyMycoses, 2018
- Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and TreatmentClinical Infectious Diseases, 2016
- Clostridium difficile infections in patients with severe burnsBurns, 2011
- Prophylactic antibiotics for burns patients: systematic review and meta-analysisBMJ, 2010
- Causes of Mortality by Autopsy Findings of Combat Casualties and Civilian Patients Admitted to a Burn UnitJournal of the American College of Surgeons, 2009
- Burn Wound InfectionsClinical Microbiology Reviews, 2006
- Bacteria and wound healingCurrent Opinion in Infectious Diseases, 2004
- An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching HospitalBurns, 2004
- Persistent wound infection delays epidermal maturation and increases scarring in thermal burnsWound Repair and Regeneration, 2002